Evidence map›Paper›PMID 27555943›Full record

ArticleActa crystallographica. Section E, Crystallographic communications2016

Crystal structure of a one-dimensional looped-chain silver(I) coordination polymer: catena-poly[[silver(I)-bis-{μ-4-[1-(5'-isopropyl-[1,1':3',1''-terphen-yl]-2'-yl)-1H-imidazol-2-yl]pyridine-κ(2) N:N'}] nitrate methanol monosolvate monohydrate].

Suk-Hee Moon, Ki-Min Park, Youngjin Kang

Abstract read
In one paragraph

Article in Acta crystallographica. Section E, Crystallographic communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Suk-Hee MoonDepartment of Food and Nutrition, Kyungnam College of Information and Technology, Busan 47011, Republic of Korea.
Ki-Min ParkResearch institute of Natural Science, Gyeongsang National University, Jinju 52828, Republic of Korea.
Youngjin KangDivision of Science Education, Kangwon National University, Chuncheon 24341, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the title compound, {[Ag(C29H25N3)2]NO3·CH3OH·H2O} n , the Ag(I) cation is four-coordinated by two pyridine N atoms and two imidazole N atoms from four individual 4-(1-(5'-isopropyl-[1,1':3',1''-terphen-yl]-2'-yl)-1H-imidazol-2-yl)pyridine (i-pro-pyim) ligands. This gives rise to a highly distorted tetra-hedral geometry with bond angles falling in the range 100.33 (19)-122.76 (19)°. Two crystallographically independent i-pro-pyim ligands (A and B) adopt very similar conformations to one another, such that the dihedral angles between the pyridyl and imidazolyl rings in the two ligands are 40.7 (3) and 42.2 (3)°, respectively. Each i-pro-pyim ligand binds two symmetry-related Ag(+) cations, leading to the formation of 14-membered cyclic dimers, in which the Ag(I) atoms are separated by 6.963 (2) Å for the Ag-A 2-Ag dimer and 7.020 (2) Å for Ag-B 2-Ag. These cyclic dimers are alternately connected to each other by sharing Ag(I) atoms, resulting in the formation of a looped-chain structure extending along the [100] direction. Moreover, adjacent looped chains are connected by inter-molecular π-π inter-actions [centroid-to-centroid distance = 3.689 (4) Å], giving rise to the formation of a two-dimensional supra-molecular network propagating parallel to (110). Several inter-molecular C-H⋯O and O-H⋯O hydrogen bonds further contribute to the stabilization of the crystal structure.

Indexed as

crystal structurelooped-chain coordination polymerpyridyl­imidazol ligandsilver(I)

Identifiers

PMID27555943
PMCPMC4992918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.